This suggests a dual role of StarD13; as 1- a tumor suppressor which attenuates RhoA (hence Raf-1/MEK/ERK proliferation and survival pathway) as well as 2- an invasion suppressor, which inhibits Cdc42. Here, MAP2K7 is linked to neoplasm.